Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Semi-synthetic vinca alkaloid found in Catharan...
α1-adrenergic antagonist.
Aminoglycoside; protein translation inhibitor.<...
B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit...
Cysteine protease inhibitor.
Degrader of IKZF1/3
AhR agonist.
Peptide, casein fragment.
Opioid neuropeptide; kyotorphin agonist.
Sulfonylurea; SUR1 antagonist.
Nav1.8 Na+ channel blocker, potential Nav1.5 Na...
PDE4 inhibitor.
Synthetic ITC, erysolin analog.
SERM.
Pt-based DNA cross-linker.
Triterpene saponin found in species of Panax.
Endogenous peptide hormone; GnRH agonist.
Triterpene saponin found in species of Panax; Î...
ITC, radical scavenger.
Major metabolite of ginsenosides Rb1, Rb2, Rc, ...